Adaptive exchange sustains cullin–RING ubiquitin ligase networks and proper licensing of DNA replication

Yaru Zhang(Amgen (United States)), Marco Jost(QB3), Ryan A. Pak(QB3), Daniel Lu(Amgen (United States)), Jing Li(Amgen (United States)), Brett Lomenick(California Institute of Technology), Spiros D. Garbis(California Institute of Technology), Chi-Ming Li(Amgen (United States)), Jonathan S. Weissman(QB3), J. Russell Lipford(Amgen (United States)), Raymond J. Deshaies(California Institute of Technology)
Proceedings of the National Academy of Sciences
August 29, 2022
Cited by 23Open Access
Full Text

Abstract

Cop9 signalosome (CSN) regulates the function of cullin–RING E3 ubiquitin ligases (CRLs) by deconjugating the ubiquitin-like protein NEDD8 from the cullin subunit. To understand the physiological impact of CSN function on the CRL network and cell proliferation, we combined quantitative mass spectrometry and genome-wide CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) screens to identify factors that modulate cell viability upon inhibition of CSN by the small molecule CSN5i-3. CRL components and regulators strongly modulated the antiproliferative effects of CSN5i-3, and in addition we found two pathways involved in genome integrity, SCF FBXO5 –APC/C–GMNN and CUL4 DTL –SETD8, that contribute substantially to the toxicity of CSN inhibition. Our data highlight the importance of CSN-mediated NEDD8 deconjugation and adaptive exchange of CRL substrate receptors in sustaining CRL function and suggest approaches for leveraging CSN inhibition for the treatment of cancer.


Related Papers

No related papers found

Powered by citation graph analysis